izpis_h1_title_alt

Serotonin-related functional genetic variants affect the occurrence of psychiatric and motor adverse events of dopaminergic treatment in Parkinson’s disease : a retrospective cohort study
ID Redenšek Trampuž, Sara (Author), ID Blagus, Tanja (Author), ID Trošt, Maja (Author), ID Dolžan, Vita (Author)

.pdfPDF - Presentation file, Download (550,02 KB)
MD5: C1C69CB8921B93E54DFA9619D5F05F1B
URLURL - Source URL, Visit https://www.mdpi.com/2075-4426/12/2/266 This link opens in a new window

Abstract
The serotonergic system is important in Parkinson’s disease (PD) pathogenesis as it can take over dopamine production after a large portion of dopaminergic neurons is lost through neurodegeneration. The aim of this study was to evaluate the effect of genetic variability of serotonergic genes on the occurrence of motor complications and psychiatric adverse events (AE) due to dopaminergic treatment. We enrolled 231 patients and their clinical data were collected. Genotyping was performed for eight genetic variants. Logistic regression was used for analysis. Carriers of the HTR1A rs6295 GC genotype (OR = 2.58; 95% CI = 1.15–5.78; p = 0.021), TPH2 rs4290270 AA genotype (OR = 2.78; 95% CI = 1.08–7.03; p = 0.034), and at least one TPH2 rs4570625 T allele (OR = 1.86; 95% CI = 1.00–3.44; p = 0.047) had increased risk for visual hallucinations (VH). Additionally, carriers of at least one SLC6A4 5-HTTPLR rs25531 S (OR = 0.52; 95% CI = 0.28–0.96; p = 0.037) or at least one L$_G$ allele (OR = 0.37; 95% CI = 0.14–0.97; p = 0.044) had a decreased chance for VH. Constructed haplotypes of the TPH2 showed increased risk for VH (OR = 1.94; 95% CI = 1.06–3.55; p = 0.032) and impulse control disorders (OR = 5.20; 95% CI = 1.86–14.50; p = 0.002). Finally, individual gene–gene interactions showed decreased odds for the development of motor AE. Our findings suggest that the serotonergic pathway may play an important role in the development of AE resulting from dopaminergic treatment.

Language:English
Keywords:Parkinson’s disease, motor complications, visual hallucinations, impulse control disorders, dyskinesia, polymorphism, serotonin, adverse event, pharmacogenomics
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:13 str.
Numbering:Vol. 12, iss. 2, art. 266
PID:20.500.12556/RUL-137342 This link opens in a new window
UDC:616.8
ISSN on article:2075-4426
DOI:10.3390/jpm12020266 This link opens in a new window
COBISS.SI-ID:97247491 This link opens in a new window
Publication date in RUL:13.06.2022
Views:531
Downloads:83
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of personalized medicine
Shortened title:J. pers. med.
Publisher:MDPI
ISSN:2075-4426
COBISS.SI-ID:31207641 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:11.02.2022

Secondary language

Language:Slovenian
Keywords:Parkinsonova bolezen, motorični zapleti, vizualne halucinacije

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0170
Name:Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku

Funder:ARRS - Slovenian Research Agency
Project number:J7-2600
Name:Presnovne možganske spremembe nevrodegenerativnih demenc in njihove korelacije s histopatološkimi spremembami v možganih

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back